Kedan Lin

1.8k total citations
25 papers, 1.1k citations indexed

About

Kedan Lin is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kedan Lin has authored 25 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 16 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kedan Lin's work include HER2/EGFR in Cancer Research (15 papers), Monoclonal and Polyclonal Antibodies Research (15 papers) and CAR-T cell therapy research (4 papers). Kedan Lin is often cited by papers focused on HER2/EGFR in Cancer Research (15 papers), Monoclonal and Polyclonal Antibodies Research (15 papers) and CAR-T cell therapy research (4 papers). Kedan Lin collaborates with scholars based in United States, France and United Kingdom. Kedan Lin's co-authors include Meric Ovacik, Jay Tibbitts, Crystal Zhang, C. Andrew Boswell, Wolfgang Sadée, Katherine R. Kozak, Keyang Xu, Surinder Kaur, Eduardo E. Mundo and Bonnee Rubinfeld and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Kedan Lin

23 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kedan Lin United States	17	750	637	431	224	71	25	1.1k
Fiona E. Smyth Australia	23	622 0.8×	625 1.0×	526 1.2×	261 1.2×	93 1.3×	39	1.3k
Anzhelika Vorobyeva Sweden	20	799 1.1×	499 0.8×	330 0.8×	66 0.3×	67 0.9×	73	1.0k
Stephen I. Rudnick United States	9	362 0.5×	270 0.4×	391 0.9×	165 0.7×	64 0.9×	11	798
Mohamed Altai Sweden	23	1.1k 1.4×	580 0.9×	425 1.0×	62 0.3×	55 0.8×	42	1.3k
Christel Vangestel Belgium	18	364 0.5×	307 0.5×	401 0.9×	74 0.3×	120 1.7×	49	1.0k
Christel Larbouret France	18	356 0.5×	652 1.0×	366 0.8×	224 1.0×	37 0.5×	36	971
Qingrong Yan United States	14	236 0.3×	366 0.6×	444 1.0×	537 2.4×	34 0.5×	17	1.0k
Christoph Roesli Switzerland	17	249 0.3×	242 0.4×	481 1.1×	142 0.6×	40 0.6×	28	918
Jay Sarup United States	14	690 0.9×	1.1k 1.8×	815 1.9×	138 0.6×	25 0.4×	15	1.7k
Sébastien Gouard France	18	450 0.6×	259 0.4×	159 0.4×	87 0.4×	52 0.7×	37	758

Countries citing papers authored by Kedan Lin

Since Specialization

Citations

This map shows the geographic impact of Kedan Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kedan Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kedan Lin more than expected).

Fields of papers citing papers by Kedan Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kedan Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kedan Lin. The network helps show where Kedan Lin may publish in the future.

Co-authorship network of co-authors of Kedan Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Kedan Lin. A scholar is included among the top collaborators of Kedan Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kedan Lin. Kedan Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lu, Ming, Panpan Zhang, Lin Shen, et al.. (2023). Abstract CT263: A phase Ib dose-expansion study of porustobart, an anti-CTLA-4 heavy chain only monoclonal antibody, in combination with toripalimab in patients with advanced high-grade neuroendocrine neoplasms (NENs). Cancer Research. 83(8_Supplement). CT263–CT263.

Boswell, C. Andrew, Daniela Bumbaca Yadav, Eduardo E. Mundo, et al.. (2019). Biodistribution and efficacy of an anti-TENB2 antibody-drug conjugate in a patient-derived model of prostate cancer. Oncotarget. 10(58). 6234–6244. 14 indexed citations

Mandikian, Danielle, Ji Li, Jeffrey Eastham‐Anderson, et al.. (2018). Relative Target Affinities of T-Cell–Dependent Bispecific Antibodies Determine Biodistribution in a Solid Tumor Mouse Model. Molecular Cancer Therapeutics. 17(4). 776–785. 112 indexed citations

Ovacik, Meric & Kedan Lin. (2018). Tutorial on Monoclonal Antibody Pharmacokinetics and Its Considerations in Early Development. Clinical and Translational Science. 11(6). 540–552. 194 indexed citations

Sukumaran, Siddharth, Crystal Zhang, Douglas D. Leipold, et al.. (2016). Development and Translational Application of an Integrated, Mechanistic Model of Antibody-Drug Conjugate Pharmacokinetics. The AAPS Journal. 19(1). 130–140. 19 indexed citations

Dillon, Michael, Yiyuan Yin, Jianhui Zhou, et al.. (2016). Efficient production of bispecific IgG of different isotypes and species of origin in single mammalian cells. mAbs. 9(2). 213–230. 58 indexed citations

Lin, Kedan, Bonnee Rubinfeld, Crystal Zhang, et al.. (2015). Preclinical Development of an Anti-NaPi2b (SLC34A2) Antibody–Drug Conjugate as a Therapeutic for Non–Small Cell Lung and Ovarian Cancers. Clinical Cancer Research. 21(22). 5139–5150. 65 indexed citations

Sukumaran, Siddharth, Kapil Gadkar, Crystal Zhang, et al.. (2014). Mechanism-Based Pharmacokinetic/Pharmacodynamic Model for THIOMAB™ Drug Conjugates. Pharmaceutical Research. 32(6). 1884–1893. 32 indexed citations

Feng, Yang, Zhongyu Zhu, Weizao Chen, et al.. (2014). Conjugates of Small Molecule Drugs with Antibodies and Other Proteins. Biomedicines. 2(1). 1–13. 20 indexed citations

10.

Kozak, Katherine R., Jianyong Wang, Josefa Chuh, et al.. (2013). Micro-volume wall-less immunoassays using patterned planar plates. Lab on a Chip. 13(7). 1342–1342. 16 indexed citations

11.

Lin, Kedan, Crystal Zhang, Eric B. Harstad, et al.. (2013). Abstract 5619: Preclinical development of anti-SLC34A2 antibody drug conjugate as a therapeutic for non-small cell lung and ovarian cancers.. Cancer Research. 73(8_Supplement). 5619–5619.

12.

Lin, Kedan, Jay Tibbitts, & Ben‐Quan Shen. (2013). Pharmacokinetics and ADME Characterizations of Antibody–Drug Conjugates. Methods in molecular biology. 1045. 117–131. 18 indexed citations

13.

Kozak, Katherine R., Siao Ping Tsai, Aimee Fourie-O’Donohue, et al.. (2013). Total Antibody Quantification for MMAE-Conjugated Antibody–Drug Conjugates: Impact of Assay Format and Reagents. Bioconjugate Chemistry. 24(5). 772–779. 24 indexed citations

14.

Gordon, Michael S., David E. Gerber, Jeffrey R. Infante, et al.. (2013). A phase I study of the safety and pharmacokinetics of DNIB0600A, an anti-NaPi2b antibody-drug-conjugate (ADC), in patients (pts) with non− small cell lung cancer (NSCLC) and platinum-resistant ovarian cancer (OC).. Journal of Clinical Oncology. 31(15_suppl). 2507–2507. 10 indexed citations

15.

Beck, Alain, John M. Lambert, Michael Sun, & Kedan Lin. (2012). Fourth World Antibody-Drug Conjugate Summit. mAbs. 4(6). 637–647. 31 indexed citations

16.

Lin, Kedan & Jay Tibbitts. (2012). Pharmacokinetic Considerations for Antibody Drug Conjugates. Pharmaceutical Research. 29(9). 2354–2366. 98 indexed citations

17.

Boswell, C. Andrew, Eduardo E. Mundo, Crystal Zhang, et al.. (2012). Differential Effects of Predosing on Tumor and Tissue Uptake of an¹¹¹In-Labeled Anti-TENB2 Antibody–Drug Conjugate. Journal of Nuclear Medicine. 53(9). 1454–1461. 42 indexed citations

18.

Boswell, C. Andrew, Eduardo E. Mundo, Ron Firestein, et al.. (2012). An integrated approach to identify normal tissue expression of targets for antibody‐drug conjugates: case study of TENB2. British Journal of Pharmacology. 168(2). 445–457. 29 indexed citations

19.

Boswell, C. Andrew, Eduardo E. Mundo, Crystal Zhang, et al.. (2011). Impact of Drug Conjugation on Pharmacokinetics and Tissue Distribution of Anti-STEAP1 Antibody–Drug Conjugates in Rats. Bioconjugate Chemistry. 22(10). 1994–2004. 155 indexed citations

20.

Lin, Kedan, Daqing Wang, & Wolfgang Sadée. (2002). Serum Response Factor Activation by Muscarinic Receptors via RhoA. Journal of Biological Chemistry. 277(43). 40789–40798. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact